Mourad G, Ribstein J, Argiles A, Mimran A, Mion C
Service de Néphrologie, University Hospital, Montpellier, France.
Nephrol Dial Transplant. 1989;4(1):66-70.
Deterioration of renal function is a major concern during treatment by converting enzyme inhibitors of hypertensive kidney recipients with transplant renal artery stenosis. However, there has been no assessment of the frequency of this complication and its specificity for converting enzyme inhibitors as compared to other antihypertensive drugs. The effect of acute administration of captopril on mean arterial pressure, glomerular filtration rate (GFR) (creatinine clearance) and effective renal plasma flow (clearance of 131I-hippuran) was assessed in eight hypertensive patients with transplant renal artery stenosis. Captopril induced a decrease in mean arterial pressure (128 +/- 6-121 +/- 7 mmHg) and a reduction in GFR (59 +/- 8-44 +/- 8 ml/min per 1.73 m2, P less than 0.05). The decrease in GFR was observed in seven out of eight patients and varied between 0% and 100% of the pre-captopril value. Effective renal plasma flow was maintained (157 +/- 47-141 +/- 24 ml/min per 1.73 m2) and filtration fraction decreased by 15 +/- 7%. The effect of captopril was compared to that of nifedipine (N = 20 mg) in four patients. Despite a larger decrease in mean arterial pressure (130 +/- 7-109 +/- 10 mmHg), no reduction in GFR was observed (68 +/- 13-71.4 +/- 8). Effective renal plasma flow was unchanged and filtration function slightly increased. Surgical or percutaneous transluminal angioplasty in five patients suppressed the captopril-induced decrease in GFR.(ABSTRACT TRUNCATED AT 250 WORDS)
对于患有移植肾动脉狭窄的高血压肾移植受者,在使用转换酶抑制剂治疗期间,肾功能恶化是一个主要问题。然而,与其他抗高血压药物相比,尚未对这种并发症的发生率及其对转换酶抑制剂的特异性进行评估。在8例患有移植肾动脉狭窄的高血压患者中,评估了急性给予卡托普利对平均动脉压、肾小球滤过率(GFR)(肌酐清除率)和有效肾血浆流量(131I-马尿酸清除率)的影响。卡托普利使平均动脉压降低(128±6 - 121±7 mmHg),GFR降低(每1.73 m²从59±8 - 44±8 ml/min,P<0.05)。8例患者中有7例出现GFR降低,降低幅度在卡托普利给药前值的0%至100%之间。有效肾血浆流量保持不变(每1.73 m²从157±47 - 141±24 ml/min),滤过分数降低了15±7%。在4例患者中,将卡托普利的效果与硝苯地平(N = 20 mg)的效果进行了比较。尽管平均动脉压下降幅度更大(130±7 - 109±10 mmHg),但未观察到GFR降低(68±13 - 71.4±8)。有效肾血浆流量未改变,滤过功能略有增加。5例患者进行手术或经皮腔内血管成形术抑制了卡托普利引起的GFR降低。(摘要截断于250字)